|
Research Studies
July 2011 (revised 6.30.11) | Study Type | Acute Coronary Syndrome
| | Title | PEGASUS Timi 54 A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events with Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients with History of Myocardial Infarction | | Study Aim | This study is assessing the prevention of thrombotic events comparing Ticagrelor with placebo on patients with a history of myocardial infarction on ASA.
| | Study Type | Atrial Fibrillation | | Title | Amplatzer Cardiac Plug
| | Study Aim | The Amplatzer Cardiac Plug is a percutaneous transcatheter device intended to prevent thrombus embolization from the left atrial appendage (LAA) in subjects who have nonvalvular atrial fibrillation.
| | Study Type | Atrial Fibrillation and Stroke | | Title | CRYSTAL AF: Cryptogenic Stroke And Underlying AF
| | Study Aim | The purpose of this study is to compare the continuous monitoring by the Reveal XT Insert able Cardiac Monitor to standard of care optimal medical treatment in subjects after diagnosis of cryptogenic stroke. This clinical trial will assess the incidence of atria fibrillation in subjects with a recent cryptogenic stroke or transient ischemic attack who are at an increased risk of cardiac arrhythmia, and aims to demonstrate the benefit of timely atrial fibrillation detection for patient care.
| | Study Type | Anticoagulation Bridging Study for Patients Undergoing an Invasive Procedure | | Title | BRIDGE--Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery
| | Study Aim | Compares the efficacy of bridging anticoagulation with no bridging anticoagulation on the rate of thrombosis or bleeding in patients with atrial fibrillation or atrial flutter who require temporary interruption of warfarin. | | Study Type | Patent Foramen Ovale and Migraine | | Title | PREMIUM--Prospective Randomized investigation to Evaluate incidence of headache reduction in subjects with Migraine and PFO Using the Amplatzer PFO Occluder to Medical Management.
| | Study Aim | Evaluate whether percutaneous PFO closure is effective in reducing the incidence of disabling migraine headaches in subjects who are refractory to medical treatment. | | Study Type | Patent Foramen Ovale and Stroke | | Title | RESPECT: Randomized Evaluation of Recurrent Stroke comparing PFO Closure to Established Current Standard of Care Treatment | | Study Aim | The purpose of this research study is to compare the AMPLATZER PFO Occluder device to medicine in preventing another stroke related to a PFO and also to evaluate the safety of the study device.
| | Study Type | GE-145 Cath Study (Contrast Study) | | Title | A Phase 2, Double-Blind, Randomized, Safety Study of GE-145 320 MG-I/ML Injection Versus Iopamidol 370 MG-I/ML In Elderly Subjects Undergoing Coronary Artery Catheterization Procedure
| | Study Aim | This study evaluates the effects of GE 145 contrast versus Isovue contrast on cardio- renal safety on high risk elderly subjects undergoing a coronary artery catheterization with or without PCI. | | Study Type | CAD & Diabetes Mellitus | | Title | EXSCEL A Randomized, Placebo Controlled Clinical Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus | | Study Aim | This study is evaluating cardiovascular Outcomes after a Diabetic Mellitus Type 2. The patient will take Exenatide once weekly.
|
|